|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.22 CAD | -4.35% |
|
0.00% | 0.00% |
| 04-05 | NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | NEXGENRX INC. Announces the Retirement of Dave Bennett from its Board of Directors | CI |
NexgenRx Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported revenue was CAD 3.46 million compared to CAD 3.17 million a year ago. Net income was CAD 0.194927 million compared to CAD 0.377956 million a year ago.
Basic earnings per share from continuing operations was CAD 0.003 compared to CAD 0.005 a year ago. Diluted earnings per share from continuing operations was CAD 0.003 compared to CAD 0.005 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 11.4M | |
| -1.09% | 117B | |
| +14.62% | 68.56B | |
| +17.80% | 62.47B | |
| +12.10% | 43.26B | |
| +14.61% | 42.9B | |
| +21.85% | 35.33B | |
| +6.19% | 25.16B | |
| -1.16% | 22.94B | |
| +7.02% | 19.67B |
NEXGENRX INC. 
